Ligand · A1IGA
A1IGA · Lansoprazole sulfide
A1IGA, Lansoprazole sulfide (C16 H14 F3 N3 O S, 353.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with…
- Component
- A1IGA
- Formula
- C16 H14 F3 N3 O S
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A1IGA in 1 structure; the first of them:
- 9FTZ · CIII2/CIV respiratory supercomplex from Mycobacterium smegmatis with lansoprazole sulfide · A1IGA N604 · binds CYS367, HIS368, PHE153, PHE156, THR169, GLY170, ALA173, ALA174 and 12 more
Residues it binds most
ALA 1, ILE 1, THR 1, MET 1, PHE 1, ASP 1, CYS 1, GLY 1, HIS 1, PRO 1 (residue and the binding sites it lines).
Found with
- 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine
- 7PH · (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate
- 9XX · (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate
- 9YF · (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1r,2r,3r,4r, 5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate
- CDL · Cardiolipin
- FES · Fe2/s2 (inorganic) cluster
- HEA · Heme-A
- HEC · Heme C
- HEM · Protoporphyrin IX containing Fe
- IZL · [(2~{R})-3-[[(1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S}, 4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S}, 6~{R})-6-(hydroxymethyl)-3-[(2~{R},3~{S},4~{S},5~{S}, 6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,5-bis(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4,5-tris(oxidanyl)-6-[(2~{R},3~{S},4~{S},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(undecanoyloxymethyl)oxan-2-yl]oxy-cyclohe
- MQ9 · Menaquinone-9
- PLM · Palmitic acid
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.